Cargando…

Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects

BACKGROUND: Dysferlin is reduced in patients with limb girdle muscular dystrophy type 2B, Miyoshi myopathy, distal anterior compartment myopathy, and in certain Ethnic clusters. METHODS: We evaluated clinical and genetic patient data from three different Swiss Neuromuscular Centers. RESULTS: Thirtee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petersen, Jens A., Kuntzer, Thierry, Fischer, Dirk, von der Hagen, Maja, Huebner, Angela, Kana, Veronika, Lobrinus, Johannes A., Kress, Wolfram, Rushing, Elisabeth J., Sinnreich, Michael, Jung, Hans H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596355/ https://www.ncbi.nlm.nih.gov/pubmed/26444858 http://dx.doi.org/10.1186/s12883-015-0449-3

Ejemplares similares

Therapeutic exon skipping for dysferlinopathies?
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2010)

Dysferlin and Animal Models for Dysferlinopathy
por: Kobayashi, Kinji, et al.
Publicado: (2012)

Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial
por: Walter, Maggie C, et al.
Publicado: (2013)

Functional and histopathological identification of the respiratory failure in a DMSXL transgenic mouse model of myotonic dystrophy
por: Panaite, Petrica-Adrian, et al.
Publicado: (2013)

Heterogeneous Characteristics of Korean Patients with Dysferlinopathy
por: Park, Hyung Jun, et al.
Publicado: (2012)

Portrait of Dysferlinopathy: Diagnosis and Development of Therapy
por: Bouchard, Camille, et al.
Publicado: (2023)

Muscle membrane repair and inflammatory attack in dysferlinopathy
por: Han, Renzhi
Publicado: (2011)

Differential Immunohistological Features of Inflammatory Myopathies and Dysferlinopathy
por: Choi, Jae-Hwan, et al.
Publicado: (2009)

Dysferlinopathy Fibroblasts Are Defective in Plasma Membrane Repair
por: Matsuda, Chie, et al.
Publicado: (2015)

Magnetic resonance imaging pattern variability in dysferlinopathy
por: Bardakov, Sergey N., et al.
Publicado: (2021)

Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy
por: Lee, Yun-Sil, et al.
Publicado: (2015)

Dysferlinopathy course and sportive activity: clues for possible treatment
por: Angelini, C., et al.
Publicado: (2011)

The Clinical Outcome Study for dysferlinopathy: An international multicenter study
por: Harris, Elizabeth, et al.
Publicado: (2016)

Serum Cytokine Profile in a Patient Diagnosed with Dysferlinopathy
por: Khaiboullina, Svetlana F., et al.
Publicado: (2017)

AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy
por: Ono, Hiroya, et al.
Publicado: (2020)

Diagnosis by protein analysis of dysferlinopathy in two patients mistaken as polymyositis
por: Angelini, Corrado, et al.
Publicado: (2011)

Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan
por: Umakhanova, Zoya R., et al.
Publicado: (2017)

Water T2 could predict functional decline in patients with dysferlinopathy
por: Moore, Ursula, et al.
Publicado: (2022)

Genetic profile for suspected dysferlinopathy identified by targeted next-generation sequencing
por: Izumi, Rumiko, et al.
Publicado: (2015)

AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models
por: Sondergaard, Patricia C, et al.
Publicado: (2015)

Assessment of disease progression in dysferlinopathy: A 1-year cohort study
por: Moore, Ursula, et al.
Publicado: (2019)

Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials
por: Diaz-Manera, Jordi, et al.
Publicado: (2018)

Corrigendum: Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan
por: Umakhanova, Zoya R., et al.
Publicado: (2017)

Clinical, Neurophysiological, Radiological, Pathological, and Genetic Features of Dysferlinopathy in Saudi Arabia
por: Alharbi, Norah, et al.
Publicado: (2022)

Key biomarkers and latent pathways of dysferlinopathy: Bioinformatics analysis and in vivo validation
por: Xie, Yan, et al.
Publicado: (2022)

Cardiac and pulmonary findings in dysferlinopathy: A 3‐year, longitudinal study
por: Moore, Ursula, et al.
Publicado: (2022)

Genome-wide expression analysis comparing hypertrophic changes in normal and dysferlinopathy mice
por: Lee, Yun-Sil, et al.
Publicado: (2015)

Dysferlin Gene Mutation Spectrum in a Large Cohort of Chinese Patients with Dysferlinopathy
por: Jin, Su-Qin, et al.
Publicado: (2016)

Serum exosomes can restore cellular function in vitro and be used for diagnosis in dysferlinopathy
por: Dong, Xue, et al.
Publicado: (2018)

Distinct Effects of Contraction-Induced Injury In Vivo on Four Different Murine Models of Dysferlinopathy
por: Roche, Joseph A., et al.
Publicado: (2012)

Dysferlin-deficient immortalized human myoblasts and myotubes as a useful tool to study dysferlinopathy
por: Philippi, Susanne, et al.
Publicado: (2012)

LGMD phenotype due to a new gene and dysferlinopathy investigated by next-generation sequencing
por: Angelini, Corrado I.
Publicado: (2015)

Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy
por: Lee, Joshua J.A., et al.
Publicado: (2018)

Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study
por: Moore, Ursula R, et al.
Publicado: (2018)

Phenotypic Drug Screening for Dysferlinopathy Using Patient‐Derived Induced Pluripotent Stem Cells
por: Kokubu, Yuko, et al.
Publicado: (2019)

Dysferlinopathy in a cohort of Chinese patients: clinical features, mutation spectrum, and imaging findings
por: Guo, Qi-Fu, et al.
Publicado: (2021)

Serum exosomes can restore cellular function in vitro and be used for diagnosis in dysferlinopathy: Erratum
por: Dong, Xue, et al.
Publicado: (2021)

The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies
por: Becker, Nicole, et al.
Publicado: (2022)

Functional recovery of a novel knockin mouse model of dysferlinopathy by readthrough of nonsense mutation
por: Seo, Kyowon, et al.
Publicado: (2021)

A rare case of dysferlinopathy with paternal isodisomy for chromosome 2 determined by exome sequencing
por: Li, Huan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3efahq67scl55m0t9a6bua2oi0